SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-052848
Filing Date
2017-10-17
Accepted
2017-10-17 16:45:48
Documents
1
Period of Report
2017-10-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv476728_3.html 3  
1 OWNERSHIP DOCUMENT tv476728_3.xml 3 3216
  Complete submission text file 0001144204-17-052848.txt   5041
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004
Business Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004 267-426-6957
Children's Hospital of Philadelphia Foundation (Reporting) CIK: 0001632060 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-35112 | Film No.: 171141053